CR20190142A - Composiciones de tesofensina - Google Patents
Composiciones de tesofensinaInfo
- Publication number
- CR20190142A CR20190142A CR20190142A CR20190142A CR20190142A CR 20190142 A CR20190142 A CR 20190142A CR 20190142 A CR20190142 A CR 20190142A CR 20190142 A CR20190142 A CR 20190142A CR 20190142 A CR20190142 A CR 20190142A
- Authority
- CR
- Costa Rica
- Prior art keywords
- tesofensine
- compositions
- diabetes mellitus
- para
- tesofensina
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16187596 | 2016-09-07 | ||
| EP16187813 | 2016-09-08 | ||
| PCT/EP2017/072462 WO2018046599A1 (en) | 2016-09-07 | 2017-09-07 | Tesofensine compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20190142A true CR20190142A (es) | 2019-05-22 |
Family
ID=59914436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20190142A CR20190142A (es) | 2016-09-07 | 2017-09-07 | Composiciones de tesofensina |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9949964B2 (es) |
| EP (1) | EP3509597A1 (es) |
| JP (1) | JP2019526641A (es) |
| KR (1) | KR20190050784A (es) |
| AU (1) | AU2017324406A1 (es) |
| BR (1) | BR112019004033A2 (es) |
| CA (1) | CA3032349A1 (es) |
| CO (1) | CO2019002853A2 (es) |
| CR (1) | CR20190142A (es) |
| DO (1) | DOP2019000052A (es) |
| EC (1) | ECSP19024033A (es) |
| IL (1) | IL264503A (es) |
| MX (1) | MX381130B (es) |
| RU (1) | RU2019109050A (es) |
| WO (1) | WO2018046599A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ759782A (en) | 2017-07-07 | 2023-06-30 | Boehringer Ingelheim Vetmedica Gmbh | Angiotensin ii receptor antagonist for the prevention or treatment of systemic diseases in cats |
| EP3996709A1 (en) | 2019-07-09 | 2022-05-18 | Boehringer Ingelheim Vetmedica GmbH | Telmisartan for the treatment of hypertension in dogs |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4140756A (en) * | 1976-06-10 | 1979-02-20 | Mead Johnson & Company | Film-coated matrix core tablet |
| JPS6038322A (ja) * | 1983-08-11 | 1985-02-27 | Fujisawa Pharmaceut Co Ltd | ジヒドロピリジンａ物質含有易溶性固形製剤 |
| ZA971525B (en) * | 1996-02-22 | 1997-10-21 | Neurosearch As | Tropane derivatives, their preparation and use. |
| US5977158A (en) * | 1996-11-28 | 1999-11-02 | Novo Nordisk A/S | Pharmaceutical formulations comprising levormeloxifene compounds |
| US6420473B1 (en) * | 2000-02-10 | 2002-07-16 | Bpsi Holdings, Inc. | Acrylic enteric coating compositions |
| US7125563B2 (en) * | 2002-04-12 | 2006-10-24 | Dava Pharmaceuticals, Inc. | Sustained release pharmaceutical preparations and methods for producing the same |
| DE102004004965B4 (de) | 2004-01-31 | 2006-01-05 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung eines 2-(Ethoxymethyl)-tropanderivates |
| EP1779851A1 (en) | 2005-10-31 | 2007-05-02 | Boehringer Ingelheim Pharma GmbH & Co.KG | Treatment of diabetes |
| US20100317572A1 (en) | 2007-12-20 | 2010-12-16 | Neurosearch A/S | Pharmaceutical composition comprising tesofensine or its analogue and an anti-obesity compound |
| US20120115837A1 (en) * | 2009-04-30 | 2012-05-10 | Takeda Pharmaceutical Company Limited | Solid Preparation |
| US10610489B2 (en) | 2009-10-02 | 2020-04-07 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof |
| EA029543B1 (ru) | 2012-02-16 | 2018-04-30 | Саниона А/С | Способ лечения, профилактики или уменьшения сердечно-сосудистых побочных эффектов тезофенсина |
-
2017
- 2017-09-07 KR KR1020197006955A patent/KR20190050784A/ko not_active Withdrawn
- 2017-09-07 EP EP17769002.1A patent/EP3509597A1/en not_active Withdrawn
- 2017-09-07 RU RU2019109050A patent/RU2019109050A/ru not_active Application Discontinuation
- 2017-09-07 US US15/698,115 patent/US9949964B2/en active Active
- 2017-09-07 CA CA3032349A patent/CA3032349A1/en not_active Abandoned
- 2017-09-07 CR CR20190142A patent/CR20190142A/es unknown
- 2017-09-07 BR BR112019004033A patent/BR112019004033A2/pt not_active Application Discontinuation
- 2017-09-07 JP JP2019533692A patent/JP2019526641A/ja active Pending
- 2017-09-07 WO PCT/EP2017/072462 patent/WO2018046599A1/en not_active Ceased
- 2017-09-07 MX MX2019002647A patent/MX381130B/es unknown
- 2017-09-07 AU AU2017324406A patent/AU2017324406A1/en not_active Abandoned
-
2019
- 2019-01-28 IL IL264503A patent/IL264503A/en unknown
- 2019-03-06 DO DO2019000052A patent/DOP2019000052A/es unknown
- 2019-03-27 CO CONC2019/0002853A patent/CO2019002853A2/es unknown
- 2019-04-05 EC ECSENADI201924033A patent/ECSP19024033A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3509597A1 (en) | 2019-07-17 |
| AU2017324406A1 (en) | 2019-05-02 |
| BR112019004033A2 (pt) | 2019-05-28 |
| US20180064700A1 (en) | 2018-03-08 |
| IL264503A (en) | 2019-02-28 |
| KR20190050784A (ko) | 2019-05-13 |
| MX2019002647A (es) | 2019-07-01 |
| WO2018046599A1 (en) | 2018-03-15 |
| ECSP19024033A (es) | 2019-04-30 |
| DOP2019000052A (es) | 2019-05-15 |
| CA3032349A1 (en) | 2018-03-15 |
| RU2019109050A (ru) | 2020-10-08 |
| MX381130B (es) | 2025-03-12 |
| US9949964B2 (en) | 2018-04-24 |
| CO2019002853A2 (es) | 2019-08-20 |
| JP2019526641A (ja) | 2019-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2019008103A2 (es) | Composiciones farmacéuticas para terapia de combinación | |
| WO2014180889A8 (en) | Methods and compositions for the treatment of cancer | |
| MX2017012864A (es) | Analogo acilado del glucagon. | |
| PH12015500724A1 (en) | 1, 2, 4-triazine derivatives for the treatment of viral infections | |
| MX2016013029A (es) | Compuestos de indanona sustituidos como modulares de gpr119 para el tratamiento de diabetes, obesidad, dislipidemia y trastornos relacionados. | |
| MX2017006437A (es) | Compuestos espiroisoquinolin-1,4'-piperidinicos con actividad multimodal contra el dolor. | |
| CO2019004131A2 (es) | Glicinato de metformina, composiciones farmacéuticas que comprenden la misma, y métodos de uso de la misma | |
| MX2015005732A (es) | Compuestos tricíclicos y métodos para hacer y utilizar los mismos. | |
| PH12017501122A1 (en) | Substituted pyridyl-cycloalkyl-carboxylic acids, compositions containing them and medical uses thereof | |
| CR20190131A (es) | 1-arilnaftiridin-3-carboxamidas 7-sustituidas y su uso | |
| PH12016501434A1 (en) | Compositions for use in the treatment of allergic conditions | |
| MX2017006513A (es) | Compuestos de tipo 1,9-diazaespiroundecano con actividad multimodal contra el dolor. | |
| CO2019002853A2 (es) | Composiciones de tesofensina | |
| WO2015044961A3 (en) | Pharmaceutical composition comprising capecitabine and cyclophosphamide | |
| WO2016072692A3 (ko) | 네크록스를 유효성분으로 함유하는 점막염 예방 또는 치료용 조성물 | |
| MX368972B (es) | Composiciones de glicoproteínas sialiladas y usos de estas. | |
| IN2013MU02576A (es) | ||
| WO2017067664A9 (en) | Oxa-diazaspiro compounds having activity against pain | |
| AR109630A1 (es) | Composiciones farmacéuticas de tesofensina | |
| WO2016100833A3 (en) | Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs | |
| EP2924024A3 (en) | Solid forms of lorcaserin hydrochloride | |
| MX2016010022A (es) | Composicion farmaceutica de amfepramona y topiramato util en el tratamiento de sobrepeso y obesidad. | |
| MX357132B (es) | Uso de la inulina para el tratamiento de manifestaciones clínicas asociadas con la cirrosis hepática. | |
| MX2016011140A (es) | Composiciones sinergisticas de aminas simpaticomimeticas, 5-hidroxitriptofano y carbidopa para la perdida de peso. | |
| IN2013MU02575A (es) |